Robotic Radiotherapy Market
Robotic Radiotherapy Market Forecasts to 2032 - Global Analysis By Product (Radiotherapy Systems, Software, 3D Cameras (Surface Guided Radiation Therapy - SGRT) and Other Products), Technology (Linear Accelerators (LINACs), Stereotactic Radiation Therapy (SRT) Systems, Particle Therapy, Image-Guided Radiation Therapy (IGRT), Intensity-Modulated Radiation Therapy (IMRT) and Other Technologies), Application, End User and By Geography
|
Years Covered |
2024-2032 |
|
Estimated Year Value (2025) |
US $1.4 BN |
|
Projected Year Value (2032) |
US $3.5 BN |
|
CAGR (2025-2032) |
13.8% |
|
Regions Covered |
North America, Europe, Asia Pacific, South America, and Middle East & Africa |
|
Countries Covered |
US, Canada, Mexico, Germany, UK, Italy, France, Spain, Japan, China, India, Australia, New Zealand, South Korea, Rest of Asia Pacific, South America, Argentina, Brazil, Chile, Middle East & Africa, Saudi Arabia, UAE, Qatar, and South Africa |
|
Largest Market |
Asia Pacific |
|
Highest Growing Market |
North America |
According to Stratistics MRC, the Global Robotic Radiotherapy Market is accounted for $1.4 billion in 2025 and is expected to reach $3.5 billion by 2032 growing at a CAGR of 13.8% during the forecast period. Robotic radiotherapy is an advanced cancer treatment method that utilizes robotic systems to deliver precise, high-dose radiation to tumors while minimizing exposure to surrounding healthy tissues. Integrating real-time imaging and adaptive motion tracking, it ensures accurate targeting even in dynamic anatomical regions. This technology enhances treatment efficacy and reduces side effects, making it ideal for complex or hard-to-reach tumors. Commonly used in stereotactic body radiotherapy (SBRT), robotic radiotherapy improves patient outcomes through increased precision, efficiency, and personalized treatment delivery.
According to the National Center for Biotechnology Information (NCBI), from 2010 to 2014, 12 centers practicing robotic surgery represented 18% of the total while by 2014 this number grew to 39 centers which made up 71% of centers utilizing robotic surgery thus demonstrating rapid industry-wide adoption.
Market Dynamics:
Driver:
Increasing global cancer prevalence
The advancements in early diagnosis and an aging population susceptible to various cancer types, healthcare providers are increasingly adopting precision-driven treatment methods. Robotic radiotherapy enables targeted radiation delivery, minimizing damage to healthy tissues while improving therapeutic efficacy. Additionally, the growing awareness of personalized oncology care is prompting hospitals and research centers to integrate robotic-assisted solutions into conventional radiotherapy protocols.
Restraint:
Complexity of operation
The integration of real-time imaging, adaptive motion tracking, and automated precision control requires specialized expertise for seamless operation. Healthcare facilities often struggle with the high initial investment and extended learning curve associated with robotic systems. Moreover, maintenance and calibration procedures demand technical proficiency, limiting accessibility in regions with constrained medical infrastructure.
Opportunity:
Increasing use of robotic radiotherapy for non-cancerous conditions
Beyond oncology, robotic radiotherapy is gaining traction in treating non-cancerous conditions such as arteriovenous malformations, trigeminal neuralgia, and functional disorders. Its ability to deliver high-dose radiation with millimeter precision makes it suitable for cases requiring minimally invasive intervention. Research in neurology and orthopedic applications is expanding the scope of robotic radiotherapy, with promising outcomes for chronic pain management and vascular abnormalities boost the market growth.
Threat:
Competition from alternative therapies
Technologies like proton therapy, immunotherapy, and advanced surgical robotics are emerging as viable alternatives for cancer and neurological disorders. Additionally, traditional radiotherapy methods continue to improve, incorporating AI-driven optimization and enhanced imaging techniques. Healthcare institutions weigh factors such as cost-effectiveness, patient outcomes, and infrastructure compatibility when selecting treatment approaches hamper the market growth.
Covid-19 Impact:
The pandemic reshape healthcare priorities, temporarily affecting the demand for robotic radiotherapy due to resource allocation towards emergency care and infection control. However, the crisis also accelerated telemedicine adoption and remote patient monitoring, indirectly boosting interest in robotic-assisted treatment. As hospitals resumed elective procedures, the need for precision-driven radiotherapy gained momentum.
The radiotherapy systems segment is expected to be the largest during the forecast period
The radiotherapy systems segment is expected to account for the largest market share during the forecast period driven by widespread adoption in oncology centers and hospitals. These systems integrate robotic precision, real-time imaging, and automated treatment planning, enhancing therapeutic accuracy. Their ability to streamline workflows and reduce patient discomfort makes them a preferred choice for radiation oncology.
The particle therapy segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the particle therapy segment is predicted to witness the highest growth rate propelled by innovations in proton and heavy-ion therapy. These modalities offer superior tumor targeting with reduced side effects, making them increasingly favorable for sensitive cancer cases. Robotic precision further enhances treatment delivery in particle therapy, ensuring consistent radiation dosing. As research validates its advantages, market expansion is expected, with hospitals and research institutions incorporating particle therapy systems into oncology programs.
Region with largest share:
During the forecast period, the Asia Pacific region is expected to hold the largest market share owing to expanding healthcare infrastructure, and technological advancements. Countries such as China, Japan, and India are investing heavily in oncology solutions, fostering demand for robotic radiotherapy. Government initiatives promoting early cancer detection and non-invasive treatment approaches are further strengthening adoption. Additionally, collaborations between medical device manufacturers and healthcare providers are accelerating the development and deployment of robotic radiotherapy systems across the region.
Region with highest CAGR:
Over the forecast period, the North America region is anticipated to exhibit the highest CAGR driven by continuous innovation in radiotherapy technologies and strong research investments. The region’s well-established healthcare ecosystem supports the integration of robotic precision in oncology treatments. Leading institutions are actively conducting clinical trials to enhance the efficacy of robotic radiotherapy, contributing to market expansion.
Key players in the market
Some of the key players in Robotic Radiotherapy Market include Accuray Incorporated, Varian Medical Systems, Elekta AB, Mevion Medical Systems, Hitachi Ltd., ViewRay Inc., IBA Group, Reflexion Medical, Theragenics Corporation, Medtronic, CIVCO Radiotherapy, Bionix Radiation Therapy, Zap Surgical Systems, Mitsubishi Electric Corporation, RaySearch Laboratories, Sumitomo Heavy Industries, Nordion Inc., and P-Cure Ltd.
Key Developments:
In May 2025, Varian Medical Systems expanded its ten-year strategic collaboration with MedServe - NSIA Advanced Medical Services Limited to enhance cancer care services in Nigeria.
In May 2025, IBA Group signed a contract with PET Pharm Bio to install a Cyclone® IKON in Taiwan, expanding its cyclotron technology footprint in Asia.
In April 2025, Mitsubishi Electric Corporation signed an agreement with HD Renewable Energy to establish a joint venture in Japan, focusing on renewable energy solutions.
Products Covered:
• Radiotherapy Systems
• Software
• 3D Cameras (Surface Guided Radiation Therapy - SGRT)
• Other Products
Technologies Covered:
• Linear Accelerators (LINACs)
• Stereotactic Radiation Therapy (SRT) Systems
• Particle Therapy
• Image-Guided Radiation Therapy (IGRT)
• Intensity-Modulated Radiation Therapy (IMRT)
• Other Technologies
Applications Covered:
• Lung Cancer & Prostate Cancer
• Breast Cancer & Colorectal Cancer
• Brain Tumors & Spinal Tumors
• Liver Cancer & Pancreatic Cancer
• Other Applications
End Users Covered:
• Hospitals
• Cancer Research Institutes
• Ambulatory Surgical Centers
• Specialty Clinics
• Academic & Research Institutions
• Other End Users
Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
o Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
Table of Contents
1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Product Analysis
3.7 Technology Analysis
3.8 Application Analysis
3.9 End User Analysis
3.10 Emerging Markets
3.11 Impact of Covid-19
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Robotic Radiotherapy Market, By Product
5.1 Introduction
5.2 Radiotherapy Systems
5.2.1 CyberKnife
5.2.2 Gamma Knife
5.2.3 Linear Accelerators (LINACs) with Robotic Patient Positioning
5.3 Software
5.3.1 Treatment Planning Systems (TPS)
5.3.2 Image-Guided Radiation Therapy (IGRT) software
5.3.3 Adaptive Radiotherapy (ART) software
5.4 3D Cameras (Surface Guided Radiation Therapy - SGRT)
5.5 Other Products
6 Global Robotic Radiotherapy Market, By Technology
6.1 Introduction
6.2 Linear Accelerators (LINACs)
6.3 Stereotactic Radiation Therapy (SRT) Systems
6.4 Particle Therapy
6.5 Image-Guided Radiation Therapy (IGRT)
6.6 Intensity-Modulated Radiation Therapy (IMRT)
6.7 Other Technologies
7 Global Robotic Radiotherapy Market, By Application
7.1 Introduction
7.2 Lung Cancer & Prostate Cancer
7.3 Breast Cancer & Colorectal Cancer
7.4 Brain Tumors & Spinal Tumors
7.5 Liver Cancer & Pancreatic Cancer
7.6 Other Applications
8 Global Robotic Radiotherapy Market, By End User
8.1 Introduction
8.2 Hospitals
8.3 Cancer Research Institutes
8.4 Ambulatory Surgical Centers
8.5 Specialty Clinics
8.6 Academic & Research Institutions
8.7 Other End Users
9 Global Robotic Radiotherapy Market, By Geography
9.1 Introduction
9.2 North America
9.2.1 US
9.2.2 Canada
9.2.3 Mexico
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 Italy
9.3.4 France
9.3.5 Spain
9.3.6 Rest of Europe
9.4 Asia Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Australia
9.4.5 New Zealand
9.4.6 South Korea
9.4.7 Rest of Asia Pacific
9.5 South America
9.5.1 Argentina
9.5.2 Brazil
9.5.3 Chile
9.5.4 Rest of South America
9.6 Middle East & Africa
9.6.1 Saudi Arabia
9.6.2 UAE
9.6.3 Qatar
9.6.4 South Africa
9.6.5 Rest of Middle East & Africa
10 Key Developments
10.1 Agreements, Partnerships, Collaborations and Joint Ventures
10.2 Acquisitions & Mergers
10.3 New Product Launch
10.4 Expansions
10.5 Other Key Strategies
11 Company Profiling
11.1 Accuray Incorporated
11.2 Varian Medical Systems
11.3 Elekta AB
11.4 Mevion Medical Systems
11.5 Hitachi Ltd.
11.6 ViewRay Inc.
11.7 IBA Group
11.8 Reflexion Medical
11.9 Theragenics Corporation
11.10 Medtronic
11.11 CIVCO Radiotherapy
11.12 Bionix Radiation Therapy
11.13 Zap Surgical Systems
11.14 Mitsubishi Electric Corporation
11.15 RaySearch Laboratories
11.16 Sumitomo Heavy Industries
11.17 Nordion Inc.
11.18 P-Cure Ltd.
List of Tables
1 Global Robotic Radiotherapy Market Outlook, By Region (2024-2032) ($MN)
2 Global Robotic Radiotherapy Market Outlook, By Product (2024-2032) ($MN)
3 Global Robotic Radiotherapy Market Outlook, By Radiotherapy Systems (2024-2032) ($MN)
4 Global Robotic Radiotherapy Market Outlook, By CyberKnife (2024-2032) ($MN)
5 Global Robotic Radiotherapy Market Outlook, By Gamma Knife (2024-2032) ($MN)
6 Global Robotic Radiotherapy Market Outlook, By Linear Accelerators (LINACs) with Robotic Patient Positioning (2024-2032) ($MN)
7 Global Robotic Radiotherapy Market Outlook, By Software (2024-2032) ($MN)
8 Global Robotic Radiotherapy Market Outlook, By Treatment Planning Systems (TPS) (2024-2032) ($MN)
9 Global Robotic Radiotherapy Market Outlook, By Image-Guided Radiation Therapy (IGRT) software (2024-2032) ($MN)
10 Global Robotic Radiotherapy Market Outlook, By Adaptive Radiotherapy (ART) software (2024-2032) ($MN)
11 Global Robotic Radiotherapy Market Outlook, By 3D Cameras (Surface Guided Radiation Therapy - SGRT) (2024-2032) ($MN)
12 Global Robotic Radiotherapy Market Outlook, By Other Products (2024-2032) ($MN)
13 Global Robotic Radiotherapy Market Outlook, By Technology (2024-2032) ($MN)
14 Global Robotic Radiotherapy Market Outlook, By Linear Accelerators (LINACs) (2024-2032) ($MN)
15 Global Robotic Radiotherapy Market Outlook, By Stereotactic Radiation Therapy (SRT) Systems (2024-2032) ($MN)
16 Global Robotic Radiotherapy Market Outlook, By Particle Therapy (2024-2032) ($MN)
17 Global Robotic Radiotherapy Market Outlook, By Image-Guided Radiation Therapy (IGRT) (2024-2032) ($MN)
18 Global Robotic Radiotherapy Market Outlook, By Intensity-Modulated Radiation Therapy (IMRT) (2024-2032) ($MN)
19 Global Robotic Radiotherapy Market Outlook, By Other Technologies (2024-2032) ($MN)
20 Global Robotic Radiotherapy Market Outlook, By Application (2024-2032) ($MN)
21 Global Robotic Radiotherapy Market Outlook, By Lung Cancer & Prostate Cancer (2024-2032) ($MN)
22 Global Robotic Radiotherapy Market Outlook, By Breast Cancer & Colorectal Cancer (2024-2032) ($MN)
23 Global Robotic Radiotherapy Market Outlook, By Brain Tumors & Spinal Tumors (2024-2032) ($MN)
24 Global Robotic Radiotherapy Market Outlook, By Liver Cancer & Pancreatic Cancer (2024-2032) ($MN)
25 Global Robotic Radiotherapy Market Outlook, By Other Applications (2024-2032) ($MN)
26 Global Robotic Radiotherapy Market Outlook, By End User (2024-2032) ($MN)
27 Global Robotic Radiotherapy Market Outlook, By Hospitals (2024-2032) ($MN)
28 Global Robotic Radiotherapy Market Outlook, By Cancer Research Institutes (2024-2032) ($MN)
29 Global Robotic Radiotherapy Market Outlook, By Ambulatory Surgical Centers (2024-2032) ($MN)
30 Global Robotic Radiotherapy Market Outlook, By Specialty Clinics (2024-2032) ($MN)
31 Global Robotic Radiotherapy Market Outlook, By Academic & Research Institutions (2024-2032) ($MN)
32 Global Robotic Radiotherapy Market Outlook, By Other End Users (2024-2032) ($MN)
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.
List of Figures
RESEARCH METHODOLOGY
We at ‘Stratistics’ opt for an extensive research approach which involves data mining, data validation, and data analysis. The various research sources include in-house repository, secondary research, competitor’s sources, social media research, client internal data, and primary research.
Our team of analysts prefers the most reliable and authenticated data sources in order to perform the comprehensive literature search. With access to most of the authenticated data bases our team highly considers the best mix of information through various sources to obtain extensive and accurate analysis.
Each report takes an average time of a month and a team of 4 industry analysts. The time may vary depending on the scope and data availability of the desired market report. The various parameters used in the market assessment are standardized in order to enhance the data accuracy.
Data Mining
The data is collected from several authenticated, reliable, paid and unpaid sources and is filtered depending on the scope & objective of the research. Our reports repository acts as an added advantage in this procedure. Data gathering from the raw material suppliers, distributors and the manufacturers is performed on a regular basis, this helps in the comprehensive understanding of the products value chain. Apart from the above mentioned sources the data is also collected from the industry consultants to ensure the objective of the study is in the right direction.
Market trends such as technological advancements, regulatory affairs, market dynamics (Drivers, Restraints, Opportunities and Challenges) are obtained from scientific journals, market related national & international associations and organizations.
Data Analysis
From the data that is collected depending on the scope & objective of the research the data is subjected for the analysis. The critical steps that we follow for the data analysis include:
- Product Lifecycle Analysis
- Competitor analysis
- Risk analysis
- Porters Analysis
- PESTEL Analysis
- SWOT Analysis
The data engineering is performed by the core industry experts considering both the Marketing Mix Modeling and the Demand Forecasting. The marketing mix modeling makes use of multiple-regression techniques to predict the optimal mix of marketing variables. Regression factor is based on a number of variables and how they relate to an outcome such as sales or profits.
Data Validation
The data validation is performed by the exhaustive primary research from the expert interviews. This includes telephonic interviews, focus groups, face to face interviews, and questionnaires to validate our research from all aspects. The industry experts we approach come from the leading firms, involved in the supply chain ranging from the suppliers, distributors to the manufacturers and consumers so as to ensure an unbiased analysis.
We are in touch with more than 15,000 industry experts with the right mix of consultants, CEO's, presidents, vice presidents, managers, experts from both supply side and demand side, executives and so on.
The data validation involves the primary research from the industry experts belonging to:
- Leading Companies
- Suppliers & Distributors
- Manufacturers
- Consumers
- Industry/Strategic Consultants
Apart from the data validation the primary research also helps in performing the fill gap research, i.e. providing solutions for the unmet needs of the research which helps in enhancing the reports quality.
For more details about research methodology, kindly write to us at info@strategymrc.com
Frequently Asked Questions
In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.
Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.
All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
We have 3 different licensing options available in electronic format.
- Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
- 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
- Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.
All our reports are typically be emailed to you as an attachment.
To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.
We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.
Request Customization
We offer complimentary customization of up to 15% with every purchase. To share your customization requirements, feel free to email us at info@strategymrc.com or call us on +1-301-202-5929. .
Please Note: Customization within the 15% threshold is entirely free of charge. If your request exceeds this limit, we will conduct a feasibility assessment. Following that, a detailed quote and timeline will be provided.
WHY CHOOSE US ?
Assured Quality
Best in class reports with high standard of research integrity
24X7 Research Support
Continuous support to ensure the best customer experience.
Free Customization
Adding more values to your product of interest.
Safe & Secure Access
Providing a secured environment for all online transactions.
Trusted by 600+ Brands
Serving the most reputed brands across the world.
